A Pilot Randomized Controlled Trial of Intravenous N-acetyl Cysteine in STEMI

Summary

The PANACEA trial is an investigator-initiated prospective, single-center, two-arm, non-blinded pilot randomized controlled trial of high-dose IV N-Acetylcysteine therapy used as an adjunct to pharmaco-invasive reperfusion in patients presenting early after a large STEMI.

Timeline

Start

2019-09-20

Primary completion

2020-11-15

Completion

2022-01-01

Drugs

Indications